By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Uniphar plc

Uniphar plc (UPR.L)

LSE Market Data in GBP, Fundamentals in EUR
£318.00
+£6.00
+1.92%
Last Update: 17 Jul 2025, 07:51
£825.45M
Market Cap
0.00
P/E Ratio (TTM)
0.67%
Forward Dividend Yield
£163.00 - £346.00
52 Week Range

UPR.L Stock Price Chart

Explore Uniphar plc interactive price chart. Choose custom timeframes to analyze UPR.L price movements and trends.

There is nothing to show.

UPR.L Company Profile

Discover essential business fundamentals and corporate details for Uniphar plc (UPR.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Distribution

IPO Date

17 Jul 2019

Employees

3.50K

CEO

Gerard Rabbette FCA

Description

Uniphar plc operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, and internationally. The company operates through three divisions: Commercial & Clinical, Product Access, and Supply Chain & Retail. The Commercial & Clinical division offers outsourced sales, marketing, and multichannel account management services to pharmaco-medical manufacturers; and distribution and support services to medical device manufacturers. The Product Access division provides on demand services, which provides access to pharmaco-medical products and treatments by developing valuable relationships and interactions between manufacturers and other healthcare stakeholders; and exclusive access services that offers bespoke distribution partnerships to pharmaceutical partners for key brands. The Supply Chain & Retail division engages in pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons; and operates a network of pharmacies under the Life, Allcare, and Hickey's brands. It also offers pharmacy support, pharmaceutical supply chain, specialist nursing and infusion, medical device distribution, healthcare technology, data intelligence and consultancy services, pharmaceutical advisory, medical affairs, and online pharmacy and product fostering services, as well as data solutions for pharma industry. Uniphar plc was founded in 1967 and is headquartered in Dublin, Ireland.

UPR.L Financial Timeline

Browse a chronological timeline of Uniphar plc corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 23 Feb 2026

Upcoming earnings on 1 Sept 2025

Dividend declared on 24 Apr 2025

A dividend of £1.07 per share was announced, adjusted to £1.07. The dividend was paid on 16 May 2025.

Earnings released on 25 Feb 2025

EPS came in at £0.15 surpassing the estimated £0.11 by +39.75%, while revenue for the quarter reached £1.16B, beating expectations by +0.73%.

Dividend declared on 12 Sept 2024

A dividend of £0.57 per share was announced, adjusted to £0.57. The dividend was paid on 4 Oct 2024.

Earnings released on 3 Sept 2024

EPS came in at £0.05 falling short of the estimated £0.07 by -28.73%, while revenue for the quarter reached £1.16B, beating expectations by +6.31%.

Earnings released on 9 May 2024

EPS came in at £0.09 falling short of the estimated £0.10 by -3.02%, while revenue for the quarter reached £1.14B, beating expectations by +0.12%.

Dividend declared on 18 Apr 2024

A dividend of £1.02 per share was announced, adjusted to £1.02. The dividend was paid on 14 May 2024.

Dividend declared on 28 Sept 2023

A dividend of £0.55 per share was announced, adjusted to £0.55. The dividend was paid on 20 Oct 2023.

Earnings released on 30 Jun 2023

EPS came in at £0.05 falling short of the estimated £0.07 by -30.29%, while revenue for the quarter reached £1.06B, beating expectations by +4.82%.

Dividend declared on 20 Apr 2023

A dividend of £1.00 per share was announced, adjusted to £1.00. The dividend was paid on 16 May 2023.

Earnings released on 31 Dec 2022

EPS came in at £0.10 surpassing the estimated £0.09 by +7.27%, while revenue for the quarter reached £955.43M, beating expectations by +5.56%.

Dividend declared on 8 Sept 2022

A dividend of £0.53 per share was announced, adjusted to £0.53. The dividend was paid on 6 Oct 2022.

Earnings released on 30 Jun 2022

EPS came in at £0.03 falling short of the estimated £0.08 by -60.75%, while revenue for the quarter reached £495.51M, missing expectations by -42.28%.

Dividend declared on 21 Apr 2022

A dividend of £0.91 per share was announced, adjusted to £0.91. The dividend was paid on 13 May 2022.

Earnings released on 31 Dec 2021

EPS came in at £0.10, while revenue for the quarter reached £821.84M.

Dividend declared on 16 Sept 2021

A dividend of £0.48 per share was announced, adjusted to £0.48. The dividend was paid on 11 Oct 2021.

Earnings released on 30 Jun 2021

EPS came in at £0.05, while revenue for the quarter reached £827.30M.

Dividend declared on 22 Apr 2021

A dividend of £1.34 per share was announced, adjusted to £1.34. The dividend was paid on 17 May 2021.

Earnings released on 31 Dec 2020

EPS came in at £0.05, while revenue for the quarter reached £858.60M.

UPR.L Stock Performance

Access detailed UPR.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
UPR.L
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
UPR.L
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More